Patent · US Active

Compositions and methods of treating cardiac fibrosis with ifetroban

US10314824B2 · kind B2 · utility

0Cited by
17References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 11, 2018
Grant dateJun 11, 2019
Priority date
Expiry dateJun 11, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D493/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to methods of treating, preventing, and/or ameliorating fibrosis syndrome, and in particular cardiac fibrosis, by administration of a therapeutically effective amount of ifetroban, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.